Discover our latest insights. 

Patients with the debilitating, inherited blood disorders sickle cell anemia and beta-thalassemia recently received news of a life-changing treatment. The FDA approved Casgevy, a groundbreaking therapy that uses a gene editing tool called CRISPR (pronounced ‘crisper’) to treat these disorders. This is the first ever approval for this innovative type of treatment, which can change the DNA code in a patient’s cells to target the underlying cause of a disease.

Measles cases are on the rise globally, despite the availability of a safe and effective vaccine that prevents the infection. In the U.K., where over 400 cases have been detected since October of 2023,1 the alarming surge has been deemed a “national incident.” As a result, the U.S. Centers for Disease Control (CDC) issued a warning for physicians to be on alert for measles cases.

The American Heart Association (AHA) recently released new analysis and recommendations for the diagnosis and treatment of a rare type of stroke, called cerebral venous thrombosis (CVT).1 CVT makes up just 3% …

Recent findings from the American Cancer Society’s latest 2024 Cancer Statistics report paint a complex picture: while overall cancer mortality rates are on a promising decline, the landscape is marred by a …